3-Vial Kit: CJC-1295 + RBL-IPA / BPC-157 + TB-500 / RBL-3 RT Research Guide: Three-Vial Reference Kit
The 3-Vial Kit: CJC-1295 + RBL-IPA / BPC-157 + TB-500 / RBL-3 RT combines three research protocols into one bundle: pulsatile GH release, tissue repair, and triple-agonist metabolic signaling.
Component overview
CJC-1295 (No DAC) + RBL-IPA — GHRH analog + selective GHRP for pulsatile growth-hormone release research.
BPC-157 + TB-500 Blend (BPC-157 + TB-500) — pentadecapeptide + thymosin β-4 fragment for tissue-repair signaling research.
RBL-3 RT — peptide reference material, 99% HPLC verified, lyophilized powder.
Compliance reminder
Sold and distributed for laboratory research use only. Not approved by the FDA for human consumption, diagnosis, treatment, or cure of any disease. Researchers are responsible for compliance with all applicable institutional, state, and federal regulations.
Frequently asked questions
What is in the 3-Vial Kit: CJC-1295 + RBL-IPA / BPC-157 + TB-500 / RBL-3 RT?
The bundle contains three 10 mg vials: CJC-1295 (No DAC) + RBL-IPA combination, BPC-157 + TB-500 Blend (BPC-157 + TB-500), and RBL-3 RT.
Why these three?
The stack covers three orthogonal research axes: GH-axis pulsatility (CJC+Ipa), tissue-repair signaling (BPC-157 + TB-500), and triple-agonist metabolic modeling (RBL-3 RT) — a common combination for first-responder-focused recovery research.
